SHELLEY JOHNSON: Open Payments
NPI 1750603130 · CHEYENNE, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$648 in 26 payments from 13 companies in 2025. Trend: 2023 $1,634 · 2024 $1,239 · 2025 $648
Food & beverage: $648
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $243 |
| PFIZER INC. | 4 | $94 |
| Astellas Pharma US Inc | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| ABBVIE INC. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Aimmune Therapeutics, Inc. | 1 | $28 |
| Lilly USA, LLC | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Boston Scientific Corporation | 1 | $22 |
Products named: Wegovy, NURTEC ODT, Veozah, ZENPEP, COMIRNATY, ZEPBOUND, FANAPT, WATCHMAN Access System.
Industry payments across WY — which companies pay providers there.
